Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis

BACKGROUND: A high-dose trivalent inactivated influenza vaccine was licensed in 2009 by the US Food and Drug Administration (FDA) on the basis of serological criteria. We sought to establish whether high-dose inactivated influenza vaccine was more effective for prevention of influenza-related visits...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Lancet Infect Dis
Autori principali: Izurieta, Hector S, Thadani, Nicole, Shay, David K, Lu, Yun, Maurer, Aaron, Foppa, Ivo M, Franks, Riley, Pratt, Douglas, Forshee, Richard A, MaCurdy, Thomas, Worrall, Chris, Howery, Andrew E, Kelman, Jeffrey
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4834448/
https://ncbi.nlm.nih.gov/pubmed/25672568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(14)71087-4
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi